James Moore: Are we rolling over for foreign predators?
Outlook How appropriate that the Business Secretary, Vince Cable, appears before the House of Lords Economic Affairs Committee to answer questions on foreign takeovers when there’s one in the offing.
It’s just that Shire Pharmaceuticals’ battle to stay out of the clutches of the US predator AbbVie hasn’t created quite the furore that Pfizer’s failed pop at AstraZeneca did, not least because neither of the parties carries much name recognition.
As with Pfizer, this isn’t just about drugs, although AbbVie could surely do with the diversity that a takeover of Shire would provide given its reliance on a single product. It’s about tax, and Shire says its stalker would quickly move its domicile to Britain if it succeeded with a bid, using a process known as “inversion” to keep its cash out of Uncle Sam’s hands.
Actually, it’s a bit hard for Shire to raise the Union flag in its defence because it just happens to be domiciled in Ireland, again for tax reasons. And, as Mr Cable pointed out, it’s difficult for the Brits to whinge about inversion given what successive governments have done to corporation tax rates with a view to attracting companies here.
But the question of whether it’s too easy to take over UK companies remains.
Britain would be foolish to adopt the tactics of the French, whose new powers to say “non” to just about any deal are probably illegal under European law, so we’ll see whether they’re tested. Regardless of that, however, they’re probably counter-productive; France might just as well say “non” to any foreign investor. Nor would it necessarily be a good thing to give ministers that sort of power here.
But Britain’s laissez-faire approach could be almost as damaging to the national interest. Professor John Kay, the economist who conducted a review of equity markets and long-term investment for the Government in 2012, argued that there is more ministers could do to make life hot for bad bidders.
He’s probably right, although such leverage needs to be used more effectively than in the case of AstraZeneca and Pfizer, when the so-called “binding undertakings” that Mr Cable and David Cameron keep banging on about were all but worthless.
- 1 Fifty Shades of Grey trailer: First look at Jamie Dornan as Christian Grey
- 2 Is Gideon Levy the most hated man in Israel or just the most heroic?
- 3 50 books for students to read this summer: From Ernest Hemingway to Gillian Flynn
- 4 Students offered grants if they tweet pro-Israeli propaganda
- 5 Israel has discovered that it's no longer so easy to get away with murder in the age of social media
Israel-Gaza conflict: Israeli targeting policy under scrutiny after shellfire hits a mother and child, a school full of refugees and a doctor’s home
Peaches Geldof: Her final day – and her fatal decision
Students offered grants if they tweet pro-Israeli propaganda
Iraq crisis: Isis orders Mosul shop keepers to cover mannequins
Israel-Gaza conflict: Israel may have committed war crimes, says UN human rights chief
Malaysia Airlines MH17 crash: Vladimir Putin is given 'one last chance' to end hostilities in Ukraine
The 'scroungers’ fight back: The welfare claimants battling to alter stereotypes
The truth about conspiracy theories is that some require considering
Arizona execution lasts two hours as killer Joseph Wood left 'snorting and gasping' for air
Malaysia Airlines MH17 crash: Ukrainian military jet was flying close to passenger plane before it was shot down, says Russian officer
Malaysia Airlines MH17 crash: Massive rise in sale of British arms to Russia
iJobs Money & Business
£20000 - £25000 per annum + OTE £40,000: SThree: SThree Group have been well e...
£18000 - £25000 per annum + OTE £40,000: SThree: Huxley Associates are looking...
£20000 - £25000 per annum + OTE £40,000: SThree: Computer Futures has been est...
£300 - £350 per day: Orgtel: Job Title: Business Analyst Rate: £300 - £350 per...